Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S H Zwillich

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Journal of Rheumatology. Supplement|September 1, 1988
Treatment of the seronegative spondyloarthropathies with sulfasalazineS H Zwillich, S S Comer, E Lee, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1997
HIV related vasculitic mononeuropathy multiplex: a role for IVIg?G Schifitto, R L Barbano, K D Kieburtz, et al.
The Journal of Rheumatology|February 24, 2001
Multifocal Staphylococcus aureus infection originating from the sacroiliac joint in a patient with rheumatoid arthritisJ H Anolik, K Wildy, S E Cohn, et al.
The Journal of Rheumatology|January 1, 1988
Universal spondylodiscitis in a patient with erosive peripheral arthritis and apatite crystal depositionS H Zwillich, H R Schumacher, T S Hoyt, et al.
DNA and Cell Biology|September 1, 1994
V alpha gene usage in rheumatoid compared with osteoarthritic synovial tissue T cellsS H Zwillich, Q Fang, T Kieber-Emmons, et al.
The Journal of Rheumatology|October 1, 1995
Fast food arthritis--a clinico-pathologic study of post-Salmonella reactive arthritisM P Samuel, S H Zwillich, G T Thomson, et al.
Annals of the Rheumatic Diseases|July 10, 2009
Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trialJ H Coombs, B J Bloom, F C Breedveld, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 17, 2025
Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programmeB King, P Mirmirani, K Lo Sicco, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Rheumatology. Supplement|September 1, 1988
Treatment of the seronegative spondyloarthropathies with sulfasalazineS H Zwillich, S S Comer, E Lee, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1997
HIV related vasculitic mononeuropathy multiplex: a role for IVIg?G Schifitto, R L Barbano, K D Kieburtz, et al.
The Journal of Rheumatology|February 24, 2001
Multifocal Staphylococcus aureus infection originating from the sacroiliac joint in a patient with rheumatoid arthritisJ H Anolik, K Wildy, S E Cohn, et al.
The Journal of Rheumatology|January 1, 1988
Universal spondylodiscitis in a patient with erosive peripheral arthritis and apatite crystal depositionS H Zwillich, H R Schumacher, T S Hoyt, et al.
DNA and Cell Biology|September 1, 1994
V alpha gene usage in rheumatoid compared with osteoarthritic synovial tissue T cellsS H Zwillich, Q Fang, T Kieber-Emmons, et al.
The Journal of Rheumatology|October 1, 1995
Fast food arthritis--a clinico-pathologic study of post-Salmonella reactive arthritisM P Samuel, S H Zwillich, G T Thomson, et al.
Annals of the Rheumatic Diseases|July 10, 2009
Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trialJ H Coombs, B J Bloom, F C Breedveld, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 17, 2025
Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programmeB King, P Mirmirani, K Lo Sicco, et al.
Pageof 2